Get more replies from employers
Send a job-specific resume in minutes.
Lilly is seeking a senior Test Architect / Tech Lead to design and own reusable test automation frameworks for Global Regulatory Affairs (GRA) and Global Scientific Communications (GSC). You will lead end-to-end delivery of key AI and agentic testing initiatives, establishing observability and synthetic data strategies across multi-agent platforms.
Role emphasizes architecture, AI evaluation (RAGAS, DeepEval, LLM-as-a-Judge), and collaboration with engineering, product, and compliance
At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.
Test Architect / Tech Lead - CTI MD Tech (GRA/GSC) Global Regulatory Affairs (GRA) Global Scientific Communications (GSC) CTI-MD Tech@Lilly Global Regulatory Affairs (GRA) and Global Scientific Communications (GSC) together own how Lilly's medicines move through health authority review, stay compliant once approved, and get communicated externally — spanning regulatory submissions, labelling, clinical trial disclosures, and scientific publications.
Both functions operate under strict compliance and audit-readiness requirements, and are scaling agentic and generative AI capabilities across their platforms, creating a growing need for consistent, reusable test automation and AI quality engineering practices across GRA and GSC.
The Test Architect / Tech Lead (R4), GRA/GSC is accountable for building the test automation frameworks and reusable testing components that drive quality engineering across GRA and GSC, with particular depth in evaluating and validating generative AI and agentic systems.
The role also carries tech lead accountability: designing and building the application architecture for GRA/GSC platforms and owning delivery of key initiatives end to end, not solely test strategy.
This is a single R4 path role by design: test standards, automation architecture, and application architecture need to be set once and held consistently rather than fragmented across roles without the seniority to drive strategic evolution end to end.
The role owns the build-out of reusable frameworks and components, drives test automation initiatives, leads delivery of key technical initiatives, and manages stakeholders to ensure quality and AI evaluation rigor scale consistently as GRA/GSC's agentic platforms mature.
Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions.
If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.
Lilly does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.
#WeAreLilly At Lilly we strive to ensure our employees are part of a team that cares about them and our shared purpose of making life better for those around the world. How do we do this? We continue to look for ways to include, innovate, accelerate and deliver while maintaining integrity, excellence and respect for people. We hope that you seek to join us on our journey as we create medicine and deliver improved outcomes for patients across the globe! #WeAreLilly